4.4428

6.37% -0.3072

Unicycive Therapeutics Inc (UNCY)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$4.75

Offen:

$4.74

24-Stunden-Volumen:

721.84K

Relative Volume:

1.57

Marktkapitalisierung:

$78.42M

Einnahmen:

Nettoeinkommen (Verlust:

$-30.54M

KGV:

-2.8663

EPS:

-1.55

Netto-Cashflow:

$-18.30M

1W Leistung:

-15.12%

1M Leistung:

-3.73%

6M Leistung:

+582.03%

1J Leistung:

+789.32%

1-Tages-Spanne:

$4.43

$4.7641

1-Wochen-Bereich:

$4.43

$5.32

52-Wochen-Spanne:

$0.4139

$8.2457

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Firmenname

Unicycive Therapeutics Inc

Sektor

Healthcare (1139)

Branche

Biotechnology (635)

Telefon

650-384-0642

Adresse

4300 EL CAMINO REAL, SUITE 210, LOS ALTOS

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-31

Neueste SEC-Einreichungen

UNCY's Discussions on Twitter

Vergleichen Sie UNCY mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
UNCY Unicycive Therapeutics Inc	4.44	83.89M	0	-30.54M	-18.30M	-1.55
VRTX Vertex Pharmaceuticals Inc	425.27	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.15	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	431.02	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	825.35	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.61	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-21	Eingeleitet	Guggenheim	Buy
2024-04-04	Eingeleitet	Piper Sandler	Overweight

Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten

10:03 AM

How Unicycive Therapeutics Inc. stock compares to growth peersWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com

10:03 AM

09:58 AM

How rising interest rates impact Unicycive Therapeutics Inc. stockWeekly Stock Report & Fast Moving Trade Plans - newser.com

09:58 AM

09:40 AM

Sentiment analysis tools applied to Unicycive Therapeutics Inc.2025 Earnings Surprises & Verified Entry Point Signals - newser.com

09:40 AM

07:05 AM

Unicycive Therapeutics to Participate in a Fireside Chat at - GlobeNewswire

07:05 AM

06:55 AM

What catalysts could drive Unicycive Therapeutics Inc. stock higher2025 Market Overview & Accurate Buy Signal Alerts - newser.com

06:55 AM

05:36 AM

What moving averages say about Unicycive Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com

05:36 AM

04:55 AM

Can Unicycive Therapeutics Inc. stock sustain institutional interestJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com

04:55 AM

04:21 AM

Live market analysis of Unicycive Therapeutics Inc.Entry Point & Expert Curated Trade Setup Alerts - newser.com

04:21 AM

04:19 AM

Will Unicycive Therapeutics Inc. stock beat EPS estimates2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com

04:19 AM

Nov 02, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect - ACCESS Newswire

Nov 02, 2025

Why Unicycive Therapeutics Inc. stock remains resilientWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com

Nov 02, 2025

Does Unicycive Therapeutics Inc. show high probability of reboundJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com

Nov 02, 2025

Identifying reversal signals in Unicycive Therapeutics Inc.2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com

Nov 02, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Raised to Hold at Wall Street Zen - MarketBeat

Nov 02, 2025

Nov 01, 2025

HC Wainwright Analysts Increase Earnings Estimates for UNCY - MarketBeat

Nov 01, 2025

Oct 31, 2025

Unicycive Leaders Sued for Touting Kidney Treatment’s Prospects - Bloomberg Law News

Oct 31, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Oct 31, 2025

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. ... - Bluefield Daily Telegraph

Oct 31, 2025

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Oct 31, 2025

Is Unicycive Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com

Oct 31, 2025

Can Unicycive Therapeutics Inc. stock hit analyst price targets2025 Top Decliners & Reliable Entry Point Alerts - newser.com

Oct 31, 2025

Custom strategy builders for tracking Unicycive Therapeutics Inc.Trade Entry Report & Long-Term Investment Growth Plans - newser.com

Oct 31, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), United Therapeutics (UTHR) and Unicycive Therapeutics (UNCY) - The Globe and Mail

Oct 31, 2025

How Unicycive Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Oct 31, 2025

Optimistic Buy Rating for Unicycive Therapeutics Driven by Promising Clinical Progress and Financial Stability - TipRanks

Oct 31, 2025

Analyzing net buyer seller activity in Unicycive Therapeutics Inc.2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com

Oct 31, 2025

Will a bounce in Unicycive Therapeutics Inc. offer an exit2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com

Oct 31, 2025

Oct 30, 2025

Guggenheim Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY) - The Globe and Mail

Oct 30, 2025

Benchmark Co. Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Oct 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire

Oct 30, 2025

Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference - The Manila Times

Oct 30, 2025

Unicycive Therapeutics to Present New Data for Oxylanthanum Carbonate at ASN Kidney Week 2025 - Quiver Quantitative

Oct 30, 2025

Unicycive (NASDAQ: UNCY) to present OLC data: 7x lower pill volume, 2x fewer pills at ASN - Stock Titan

Oct 30, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alkermes (ALKS), Arcutis Biotherapeutics (ARQT) and Unicycive Therapeutics (UNCY) - The Globe and Mail

Oct 30, 2025

Oct 29, 2025

HC Wainwright & Co. Maintains Unicycive Therapeutics (UNCY) Buy Recommendation - Nasdaq

Oct 29, 2025

Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright - TipRanks

Oct 29, 2025

Is Unicycive Therapeutics Inc. stock attractive for growth ETFs2025 Buyback Activity & Fast Momentum Stock Entry Tips - fcp.pa.gov.br

Oct 29, 2025

Oct 28, 2025

Can Unicycive Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - Fundação Cultural do Pará

Oct 28, 2025